Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

. 2009 Jan;50(1):80-8.
doi: 10.1016/j.jhep.2008.07.023. Epub 2008 Sep 21.

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

Affiliations

"V体育官网" Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

Man-Fung Yuen et al. J Hepatol. 2009 Jan.

Abstract

Background/aims: To determine whether gender, age, hepatitis B virus genotype, core promoter and precore mutations, HBeAg/ anti-HBe status, HBV DNA, ALT levels and cirrhosis on presentation were independent risk factors and derive a novel risk score for the development of HCC VSports手机版. .

Methods: CHB patients (820) were followed up (mean duration 76. 8 months) for the occurrence of HCC V体育安卓版. .

Results: The 5- and 10-year prevalence of HCC were 4. 4% and 6. 3%, respectively V体育ios版. Cox regression analysis showed that male gender (p = 0. 025, RR 2. 98), increasing age (p < 0. 001, RR 1. 07), higher HBV DNA levels (p = 0. 02, RR 1. 28), core promoter mutations (p = 0. 007, RR 3. 66), and presence of cirrhosis (p < 0. 001, RR 7. 31) were independent risks for the development of HCC. A risk score was derived and validated with sensitivity > 84% and specificity > 76% to predict the 5- and 10- year risks for the development of HCC. The AUC for the 5- and 10-year prediction were 0. 88 and 0. 89, respectively. .

Conclusions: The risk score, based on age, gender, HBV DNA levels, core promoter mutations and cirrhosis, can estimate the chance of development of HCC in 5 and 10 years after presentation. It can be used to identify high-risk CHB patients for treatment and screening of HCC. VSports最新版本.

PubMed Disclaimer

Comment in

  • Settling the "score" with liver cancer.
    Koh C, Liang TJ. Koh C, et al. J Hepatol. 2009 Jan;50(1):7-9. doi: 10.1016/j.jhep.2008.10.008. Epub 2008 Oct 29. J Hepatol. 2009. PMID: 19014877 Free PMC article. No abstract available.

"V体育2025版" MeSH terms

"V体育安卓版" Substances